Back to Search
Start Over
Humoral immune responses to CTL epitope peptides from tumor-associated antigens are widely detectable in humans: A new biomarker for overall survival of patients with malignant diseases.
- Source :
-
Developmental & Comparative Immunology . Sep2013, Vol. 41 Issue 1, p68-76. 9p. - Publication Year :
- 2013
-
Abstract
- Highlights: [•] Humoral immune responses to CTL epitope peptides were widely detectable in humans. [•] Anti-peptide IgG correlated with overall survival (OS) in malignancies. [•] Measurement of anti-peptide IgG could be a prognostic marker for OS of malignancies. [Copyright &y& Elsevier]
Details
- Language :
- English
- ISSN :
- 0145305X
- Volume :
- 41
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Developmental & Comparative Immunology
- Publication Type :
- Academic Journal
- Accession number :
- 89107021
- Full Text :
- https://doi.org/10.1016/j.dci.2013.04.004